Researchers Turn Skin Cells into Motor Neurons Without Using Stem Cells – Futurism
Futurism |
Researchers Turn Skin Cells into Motor Neurons Without Using Stem Cells
Futurism Why build something from the ground up when one can just renovate an already existing structure? Essentially, that’s what researchers from the University of Washington School of Medicine in St. Louis had in mind when they developed a method for … Improved stem cell transplantation therapies?Science Daily Can Stem Cells Be Tricked?USC Viterbi School of Engineering (press release) (blog) |
The Tidings |
A bioethicist’s take on child cancer treatment that uses gene therapy …
The Tidings A genetic modification therapy designed for treating pediatric leukemia has drawn both praise and caution from a Catholic bioethicist, after recently being … FDA approves first gene therapy ever in US – WNDU 16WNDU-TV |
The Tidings |
A bioethicist’s take on child cancer treatment that uses gene therapy
The Tidings A genetic modification therapy designed for treating pediatric leukemia has drawn both praise and caution from a Catholic bioethicist, after recently being approved by the Food and Drug Administration. While a “promising” use of gene modification … |
Reuters |
FDA widens holds on immunotherapy combination blood cancer trials
Reuters (Reuters) – U.S. health regulators stopped five blood cancer trials testing AstraZeneca Plc’s immunotherapy Imfinzi in combination with Celgene Corp medicines from accepting new patients and halted another study entirely, the companies said on Thursday. Pharmalittle: FDA places hold on Celgene and Bristol trials; AstraZeneca-Amgen asthma drug looks strongSTAT |
Reuters |
FDA widens holds on immunotherapy combination blood cancer trials
Reuters (Reuters) – U.S. health regulators stopped five blood cancer trials testing AstraZeneca Plc’s immunotherapy Imfinzi in combination with Celgene Corp medicines from accepting new patients and halted another study entirely, the companies said on Thursday. Pharmalittle: FDA places hold on Celgene and Bristol trials; AstraZeneca-Amgen asthma drug looks strongSTAT FDA puts Celgene’s multiple cancer trials on holdDaily Mail |